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FOOD SAFETY
Shark Fin 
Consumption 
May Expose 
People to 
Neurotoxic 
BMAA
Shark-fin  soup  has  gotten  a  bad 
rap since conservation groups began 
raising awareness of shark finning, 
a practice in which fishermen slice 
the fins off the animals, sometimes 
while they are still alive, and discard 
the bodies overboard. Now, scien-
tists have found another reason to 
avoid the Asian delicacy: it may be 
detrimental to neurologic health.
Worldwide, an estimated 26–73 million 
sharks are traded on the fin market annually.
1 
Shark fin and cartilage are also sold as powder 
or in capsules, and traditional Chinese medi-
cine claims it nourishes the blood, enhances 
appetite,  and  energizes  multiple  internal 
organs.
2 However , the U .S. Food and Drug 
Administration has not confirmed any health 
benefits, and a 2004 court injunction required 
one  company  to  pay  restitution  to  custom-
ers who purchased shark-fin products falsely 
claiming to treat cancer and HIV.
3
Deborah  Mash,  a  neuroscientist  at  the 
University of Miami Medical School, led the 
first study to show shark tissues contain the 
neurotoxic  amino  acid  β-methylamino-l-
alanine  (BMAA).
4  The  nonprotein  amino 
acid is produced by cyanobacteria (sometimes 
called  “blue-green  algae”),  which  are  often 
associated  with  nutrient  runoff  in  coastal 
waters, although huge blooms also occur in 
the open ocean. BMAA has received attention 
due to increasing evidence that consumption 
of contaminated food or water may contribute 
to  amyotrophic  lateral  sclerosis,  Alzheimer 
disease, and Parkinson disease.
5 
Mash  collaborated  with  Neil  Hammer-
schlag, a University of Miami research assis-
tant professor, who captured sharks in Florida 
coastal waters. BMAA was detected in 23 of 
29 fin samples and in all species tested—nurse, 
great hammerhead, lemon, bull, bonnet  head, 
black nose, and blacktip sharks—at concentra-
tions of 144–1,836 ng/mg wet weight. BMAA 
levels in shark fins fell within the range Mash 
measured in a previous study
6 of the brains 
of humans who died from neuro  degenerative 
disease, which she says suggests BMAA has 
biomagnified in these top predators.
The scientists also tested a few samples of 
organ tissue from great hammerheads killed in 
recreational  fisheries.  BMAA  levels  averaged 
1,450 ng/mg in kidney, 588 ng/mg in liver, 
and 58 ng/mg in muscle. None was detected 
in heart tissue. By comparison, eight hammer-
head fins averaged 1,028 ng/mg.
“What  the  shark  is  teaching  us  is  that, 
like man, apex predators are probably getting 
exposed to BMAA through their diet,” says 
Mash. Past studies have detected high levels of 
BMAA in some fish and crustaceans in Florida 
waters, including pink shrimp and blue crabs, 
which both humans and sharks consume.
7
Sharks  typically  contain  high  mercury 
levels,
8 and a recent study by Doug Lobner, 
a biomedical science professor at Marquette 
University, showed that mercury and BMAA 
act  synergistically  to  kill  neurons  at  levels 
lower  than  either  substance  alone.
9 Multiple 
environmental  neurotoxicants  combined 
with a genetic risk factor “could be precisely 
the one–two punch to put you at increased 
risk  for  a  degenerative  brain  disease,”  Mash 
speculates.
The  Florida  shark  population  sampled 
likely makes up a relatively small portion of the 
global fin trade, but the findings have implica-
tions  for  sharks  worldwide.  “The  shark  [in 
Florida] is biologically the same as anywhere 
else,  and  there’s  cyanobacteria  everywhere,” 
Hammerschlag says. 
Shelley  Clarke,  a  shark-fin  trade  expert 
at Imperial College, London, says it is safe to 
assume that all the species tested in the paper 
are used in the shark-fin trade. “Some of the 
species  have  been  confirmed  present  in  the 
trade through genetic analysis,” she says. 
Great hammerhead fins are highly valued, 
and blacktip and bull sharks have extensive 
global distributions, according to Mahmood 
Shivji, director of the Guy Harvey Research 
Institute at Nova Southeastern University in 
Fort  Lauderdale,  Florida. 
“Certainly if BMAA occurs 
in  great  hammerhead  fins 
that  come  from  parts  of 
the  world  where  they  are 
captured  for  the  fin  trade, 
that  is  a  likely  avenue  for 
human  consumption,” 
he  says.  BMAA  does  not 
change  when  it’s  cooked,
10 
but  Clarke  says  anecdotal 
evidence  from  the  Hong 
Kong  fin  trade  suggests 
some  fins  may  be  treated 
with  formaldehyde,  and  it 
is not certain whether such 
a  practice  would  change 
BMAA bioavailability.
Still,  more  research  is 
needed  to  make  a  case  for 
human  risk.  “To  make  a 
stronger  case,  it  would  be  useful  to  look  at 
fins  obtained  from  the  market  and  from 
species most common in the fin trade,” says 
Shivji (those include blue sharks,
1 which were 
not tested because they are not found in the 
study  area).  “Consumption  risk  assessments 
done  for  pollutants  in  food  require  estima-
tion  of  concentrations  and  calculations  of 
consumption  in  relation  to  consumer  body 
mass and development stage.” However, the 
results suggest that consumption of shark-fin 
products may pose a significant health risk for 
degenerative brain diseases.
Award-winning  freelance  writer  Wendee  Holtcamp  has 
previously  written  about  sharks  and  scuba  dove  with  them 
while reporting for Discovery Channel’s Shark Week.
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Shark finning is a lucrative practice—these shark fins are 
being sold for $208 and $198 a pound at this store in San 
Francisco’s Chinatown in 2011. In Chinese culture, serving 
shark-fin soup is a symbol of wealth and good fortune. 